Aug 2026· Statistica sinica· 0 citations· 22 references
Mathematics
TL;DR
A new inference method for conducting multiple-treatment comparisons involving endpoints within the generalized linear model (GLM) framework under covariate-adaptive randomization (CAR) that can effectively control Type I error while potentially improving power.
Abstract
Modern medical research, such as dose-finding studies, seamless trials, and shared control designs, often involves comparing multiple treatments simultaneously. Despite its wide applications, most research focuses on continuous endpoints, leaving the inference for general outcome types in high demand. In this article, we propose a new inference method for conducting multiple-treatment comparisons involving endpoints within the generalized linear model (GLM) framework under covariate-adaptive randomization (CAR). First, we investigate the asymptotic properties of the standard Wald z-statistics (z-scores) in multi-arm trials, highlighting issues when the working model is misspecified, particularly through omitted covariates. Our theoretical findings reveal that these \textcolor{black}{z-scores} do not consistently converge to a standard multivariate normal distribution, leading to either conservative or inflated Type I error rates, depending on the specific GLM endpoint. Second, based on these theoretical results, we develop adjusted test statistics to correct the distributional problems. To appropriately control the family-wise Type I error rate inherent in multi-arm comparisons, we incorporate our adjusted statistics with Simes-type multiple-testing procedures. This robust inference method can effectively control Type I error while potentially improving power. Extensive simulation studies and a real-world application to a metastatic breast cancer trial confirm the effectiveness and practicality of our approach.
The log-rank test and Kaplan--Meier plot are standard tools for analyzing time-to-event data in randomized clinical trials, yet neither provides a summary of the magnitude of the treatment effect. Practitioners typically fill this gap by reporting a hazard ratio from a Cox proportional-hazards model or an acceleration...
L. D. McGowan, Joseph Rigdon, Xinran Li et al.· 0 citations
Marginal Mann-Whitney effects are widely used across various fields of research, and extensions of this estimand have been developed in many directions in statistical methodology. In this paper, we focus on an extensions for repeated measurements and factorial designs subject to randomly missing data. In a previous wor...
Dennis Dobler, Jörg-Tobias Kuhn, L. Amro et al.· 0 citations
Adjusting for baseline covariates has become standard practice in analyzing randomized clinical trials. In the low-dimensional setting, it is well understood that covariate adjustment through a parametric working model can sometimes be more efficient than the unadjusted difference-in-mean estimator. However, when the n...
Si-Hui Zhao, Xin-Bo Wang, Yongyong Ren et al.· 0 citations
Longitudinal continuous outcomes in clinical trials are commonly analyzed using mixed models for repeated measures (MMRM) under normality assumptions. However, many clinical outcomes are skewed, making mean-based treatment effects difficult to interpret and potentially reducing statistical efficiency. The Box--Cox MMRM...
K. Maruo, Ryota Ishii, Yusuke Yamaguchi et al.· 0 citations
The efficient randomized-adaptive design attains the minimal possible variance of the allocation proportion for any pre-specified target and has been extended from two to several treatment arms, but both versions target a single response. Confirmatory trials increasingly rely on several prioritized endpoints, typically...
An overall treatment effect in a clinical trial may inadequately represent particular patient subgroups, creating uncertainty about whether a population-level efficacy conclusion can legitimately be transferred to them. Conventional interaction tests only investigate whether subgroup-specific treatment effects are exac...
Lukas Koletzko, Holger Dette, B. Bornkamp et al.· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.